Skip to content Skip to sidebar Skip to footer

Samsung Bioepis and Phrontline Sign Global Strategic Partnership to Develop Advanced ADC Therapies for Solid Tumors

Shots:                                                                                                                                                            Samsung Bioepis and Phrontline Biopharma have entered a global agreement to develop, manufacture, and commercialize two ADC assets, including TJ108Under the deal, Phrontline will receive an upfront payment…